Not finding it? Sign in to also search OpenAlex live.
-
Impact of Primary Chronic Immune Thrombocytopenia and Thrombopoietin Receptor Agonists Treatment Instructions on Daily Living: Results of a Multinational Cross-Sectional Survey2025 Patient Preference and Adherence article Medicine Platelet Disorders and Treatments Open access
Jaap Jan Zwaginga, Srikanth Nagalla, Mark van der Linden, Caroline Kruse, Mervyn Morgan, Cecilie Yssing, +2 more
1citations -
Congenital amegakaryocytic thrombocytopenia presenting with a new thrombopoietin receptor (MPL) pathogenic variant: An instructive neonatal case2022 Journal of Paediatrics and Child Health article Medicine Platelet Disorders and Treatments Open access
Inez M Vanholder, Ginette M. Ecury‐Goossen, Jop Admiraal, Leendert Porcelijn, Rosalina ML van Spaendonk, Samantha Claudia Gouw
1citations -
CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes2021 Stem Cell Reports article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kathrin Olschok, Lijuan Han, Marcelo A. S. Toledo, Janik Böhnke, Martin Graßhoff, Ivan G. Costa, +14 more
25citations -
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry2024 Cell Communication and Signaling article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Vikas Bhuria, Tobias J. Franz, Conny K. Baldauf, Martin Böttcher, Nicolas Chatain, Steffen Koschmieder, +5 more
18citations -
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia2022 New England Journal of Medicine article Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Régis Peffault de Latour, Austin Gladston Kulasekararaj, Simona Iacobelli, Sofie Rosanne Terwel, Riley Cook, Morag Griffin, +44 more
324citations -
OC 25.5 Kinetics of platelet response with ianalumab plus eltrombopag vs eltrombopag alone in patients with primary immune thrombocytopenia (ITP) treated in the second-line setting in the randomized, double-blind, phase 3 VAYHIT2 study2026 Research and Practice in Thrombosis and Haemostasis article Medicine Platelet Disorders and Treatments Open access
Francesco F. Zaja, Hanny T. Al-Samkari, Nichola Cooper, Martina Crysandt, Waleed Ghanima, Marc Michel, +7 more
0citations -
Pharmaceutical Stability of Romiplostim: In-use Functional Study Using Microscale Thermophoresis New Strategy and Elisa2026 Pharmaceutical Research article Biochemistry, Genetics and Molecular Biology Protein purification and stability Open access
Jesús Hermosilla, Salvador Casares, Julio Ruiz-Travé, Anabel Torrente-López, Antonio Salmerón‐García, José Cabeza, +1 more
0citations -
Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial2026 Blood article Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Britta Höchsmann, Philippe Schafhausen, Fabian Beier, Michael Heuser, Jörg Westermann, Beatrice Drexler, +13 more
0citations -
IL3 Has a Detrimental Effect on Hematopoietic Stem Cell Self-Renewal in Transplantation Settings2022 International Journal of Molecular Sciences article Medicine Hematopoietic Stem Cell Transplantation Open access
Parisa Tajer, Kirsten Canté-Barrett, Brigitta A. E. Naber, Sandra A. Vloemans, Marja C.J.A. van Eggermond, Marie‐Louise van der Hoorn, +2 more
20citations